Aug 06, 2019
New Test Capable of Detecting Clinically Significant Prostate Cancer in Small Blood Sample
Jul 29, 2019
Galmed Pharmaceuticals to Report Second Quarter 2019 Financial Results and Provide Business Update on Monday, August 5
Jul 24, 2019
Stratify Genomics Announces Additional $2.2M Seed Series Funding
Jul 11, 2019
New BRCA Blue campaign educates about the link between BRCA gene mutations and cancer
Jul 10, 2019
ProMIS Neurosciences to Present Data at 2019 Alzheimer's Association International Conference
Jul 09, 2019
Applied BioMath, LLC to Present at Alzheimer's Association International Conference®
Jul 09, 2019
ProMIS Neurosciences' Data for Alzheimer's Disease Clinical Candidate PMN310 Published in Scientific Reports
Jun 27, 2019
The National Osteoporosis Foundation Launches a First-of-its-Kind Tool to Collect Patient Input for the Osteoporosis Field
Jun 27, 2019
ProMIS Neurosciences' PMN310 Shows Greater Therapeutic Potential vs. Other Amyloid-Beta-Directed Antibodies
Jun 19, 2019
Sophiris Bio Receives Positive Feedback from European Medicines Agency Regarding Phase 3 Localized Prostate Cancer Clinical Trial Design
Jun 17, 2019
Immunotherapy Study for Prostate Cancer Active Surveillance Completes Enrollment
Jun 10, 2019
Multicenter Study Validates SelectMDx's High Negative Predictive Value and Sensitivity for Prostate Cancer
Jun 06, 2019
Bellingham Urology Group Acquires First ExactVu(TM) Micro-Ultrasound System in Washington State for Real-Time Targeted Prostate Biopsies
Jun 05, 2019
ProMIS Neurosciences Presents Lead Program for Alzheimer's Disease at Prestigious Keystone Symposia Scientific Conference
Jun 04, 2019
Nanostics Announces Launch of its Clinical Validation Study for ClarityDX Prostate
May 20, 2019
CSA Medical Announces Data Presented at Digestive Disease Week 2019 Supporting truFreeze Spray Cryotherapy for the Treatment of Barrett's Esophagus
May 15, 2019
Enzyme PHLPP2 could be a viable drug target for treating prostate cancer
May 14, 2019
oneAMYLOIDOSISvoice.com Support Group Platform Begins Empowering the Amyloidosis Community with Invaluable Info About Amyloidosis Symptoms, Diagnosis, Treatment, Survival
May 13, 2019
Positive Data From The Remetinostat Phase II Study in Basal Cell Carcinoma Presented at SID Annual meeting
May 07, 2019
Data From the Remetinostat Phase II Study in Basal Cell Carcinoma Patients to be Presented at the 2019 SID Annual Meeting